Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET) announced that Chen Schor, President and CEO, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on February 8, 2024. The event will feature a live audio webcast accessible on the company's website. Adicet Bio is a clinical stage biotechnology company focusing on allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 6^th Annual Biotechnology Conference being held from February 7-8, 2024 in New York.

Details of the event are as follows:

Date: Thursday, February 8, 2024
Time: 3:00 p.m. ET

The live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205899745/en/

Adicet Bio., Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

What is the ticker symbol for Adicet Bio, Inc.?

The ticker symbol for Adicet Bio, Inc. is ACET.

When is Chen Schor participating in the fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference?

Chen Schor will participate in the fireside chat on February 8, 2024.

What is the focus of Adicet Bio, Inc.?

Adicet Bio, Inc. focuses on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.

Where can the live audio webcast of the presentation be accessed?

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com.

How long will the archived replay of the presentation be available?

The archived replay will be available for 30 days following the presentation.